Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 12668 | 827 | 53.1 | 91% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 293 | 18115 | METABOTROPIC GLUTAMATE RECEPTOR//METABOTROPIC GLUTAMATE RECEPTORS//LONG TERM POTENTIATION |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | NEUROLIGIN | Author keyword | 90 | 69% | 9% | 77 |
| 2 | SHANK3 | Author keyword | 66 | 79% | 5% | 42 |
| 3 | NEUREXIN | Author keyword | 40 | 50% | 7% | 58 |
| 4 | 22Q13 DELETION SYNDROME | Author keyword | 37 | 100% | 2% | 14 |
| 5 | 22Q133 DELETION SYNDROME | Author keyword | 27 | 92% | 1% | 11 |
| 6 | 22Q13 DELETION | Author keyword | 24 | 82% | 2% | 14 |
| 7 | PHELAN MCDERMID SYNDROME | Author keyword | 21 | 75% | 2% | 15 |
| 8 | NEUROLIGINS | Author keyword | 15 | 82% | 1% | 9 |
| 9 | NEUREXINS | Author keyword | 13 | 62% | 2% | 13 |
| 10 | SHANK2 | Author keyword | 12 | 86% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | NEUROLIGIN | 90 | 69% | 9% | 77 | Search NEUROLIGIN | Search NEUROLIGIN |
| 2 | SHANK3 | 66 | 79% | 5% | 42 | Search SHANK3 | Search SHANK3 |
| 3 | NEUREXIN | 40 | 50% | 7% | 58 | Search NEUREXIN | Search NEUREXIN |
| 4 | 22Q13 DELETION SYNDROME | 37 | 100% | 2% | 14 | Search 22Q13+DELETION+SYNDROME | Search 22Q13+DELETION+SYNDROME |
| 5 | 22Q133 DELETION SYNDROME | 27 | 92% | 1% | 11 | Search 22Q133+DELETION+SYNDROME | Search 22Q133+DELETION+SYNDROME |
| 6 | 22Q13 DELETION | 24 | 82% | 2% | 14 | Search 22Q13+DELETION | Search 22Q13+DELETION |
| 7 | PHELAN MCDERMID SYNDROME | 21 | 75% | 2% | 15 | Search PHELAN+MCDERMID+SYNDROME | Search PHELAN+MCDERMID+SYNDROME |
| 8 | NEUROLIGINS | 15 | 82% | 1% | 9 | Search NEUROLIGINS | Search NEUROLIGINS |
| 9 | NEUREXINS | 13 | 62% | 2% | 13 | Search NEUREXINS | Search NEUREXINS |
| 10 | SHANK2 | 12 | 86% | 1% | 6 | Search SHANK2 | Search SHANK2 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BETA NEUREXINS | 236 | 86% | 14% | 119 |
| 2 | ALPHA NEUREXINS | 152 | 80% | 11% | 95 |
| 3 | LNS DOMAIN | 52 | 100% | 2% | 18 |
| 4 | NEUROLIGIN | 48 | 71% | 5% | 39 |
| 5 | INHIBITORY SYNAPSE FORMATION | 40 | 82% | 3% | 23 |
| 6 | NEUROLIGINS | 33 | 47% | 6% | 52 |
| 7 | 22Q13 DELETION SYNDROME | 27 | 70% | 3% | 23 |
| 8 | AUTISM REVEALS | 27 | 92% | 1% | 11 |
| 9 | NEUROLIGIN 1 | 23 | 69% | 2% | 20 |
| 10 | TRANSSYNAPTIC INTERACTION | 23 | 76% | 2% | 16 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The Emerging Role of SHANK Genes in Neuropsychiatric Disorders | 2014 | 23 | 55 | 71% |
| Translational neurobiology in Shank mutant mice - Model systems for neuropsychiatric disorders | 2015 | 1 | 20 | 90% |
| Modeling Autism by SHANK Gene Mutations in Mice | 2013 | 46 | 126 | 45% |
| Activity-dependent neuronal signalling and autism spectrum disorder | 2013 | 104 | 97 | 19% |
| A synaptic trek to autism | 2009 | 222 | 47 | 30% |
| Deletion 22q13.3 syndrome | 2008 | 68 | 17 | 71% |
| SHANK3 as an autism spectrum disorder-associated gene | 2013 | 9 | 28 | 75% |
| Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies | 2011 | 46 | 88 | 53% |
| The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders | 2009 | 111 | 135 | 40% |
| Neurexins | 2013 | 6 | 128 | 77% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SYN T BRAIN DYSFUNCT | 7 | 43% | 1.5% | 12 |
| 2 | ANAT MOL NEUROBIOL | 4 | 39% | 1.1% | 9 |
| 3 | WG MOL ANAL SYN TOPATHIES | 3 | 43% | 0.7% | 6 |
| 4 | SEAVER AUTISM TREATMENT | 3 | 18% | 1.7% | 14 |
| 5 | QINGZHOU CLIN | 2 | 67% | 0.2% | 2 |
| 6 | AG MOL NEUROBIOL | 2 | 24% | 0.8% | 7 |
| 7 | URA GENES SYN SES COGNIT 2182 | 2 | 26% | 0.7% | 6 |
| 8 | CREAT INITIAT SYN TOGENESIS | 2 | 23% | 0.8% | 7 |
| 9 | NANCY PRITZKER | 2 | 11% | 1.7% | 14 |
| 10 | OFF BIOINFORMAT EPIDEMIOL | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000263604 | BTBR//BTBR T PLUS TF J//BTBR MICE |
| 2 | 0.0000221827 | ZNF804A//MCLAUGHLIN//MOL CLIN NEUROBIOL |
| 3 | 0.0000172844 | HOMER PROTEINS//HOMER//HOMER1 |
| 4 | 0.0000124565 | WS HALL PSYCHIAT//BROAD AUTISM PHENOTYPE//HYPERSEROTONEMIA |
| 5 | 0.0000116416 | MAGUK//PDZ DOMAIN//PSD 95 SAP90 |
| 6 | 0.0000100235 | STARGAZIN//PICK1//AMPA RECEPTOR |
| 7 | 0.0000096544 | LRIG1//LRIG3//LRIG2 |
| 8 | 0.0000094889 | ALPHA LATROTOXIN//CD97//LATROPHILIN |
| 9 | 0.0000092539 | NECTIN//TSLC1//AFADIN |
| 10 | 0.0000085112 | DREBRIN//DENDRITIC SPINE//DENDRITIC SPINES |